Bloom Medicinals, which made its debut in the UK in 2017, is planning to expand its business from its UK headquarters in Manchester to its London headquarters, according to its CEO.
The company was founded by two former executives of the company behind the popular Botox and anti-aging product Revlon.
“We are looking to be in London in the coming months,” Bloom CEO Paul Waugh told The Guardian newspaper.
“It’s not something that has been in the works for a long time.
I’m quite excited about that.”
Bloom will be the first US company to open an office in the city.
The company has previously made an in-depth foray into the London area with its medical-grade Botox brand.